Document is current
Any future updates will be listed below
-
Authors
Zhu, Qiang
Jiang, Jie
Gendron, Tania F. https://orcid.org/0000-0002-7335-2627
McAlonis-Downes, Melissa
Jiang, Lulin
Taylor, Amy
Diaz Garcia, Sandra
Ghosh Dastidar, Somasish
Rodriguez, Maria J.
King, Patrick
Zhang, Yongjie
La Spada, Albert R.
Xu, Huaxi
Petrucelli, Leonard
Ravits, John
Da Cruz, Sandrine
Lagier-Tourenne, Clotilde https://orcid.org/0000-0002-3058-8322
Cleveland, Don W. https://orcid.org/0000-0002-1934-3682
-
Funding
Funding for this research was provided by:
Amyotrophic Lateral Sclerosis Association (18-IIA-407, 2313)
Muscular Dystrophy Association (479769)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (P01-NS099114, P01-NS084974, R01-NS088689, P01-NS099114, R01-NS27036, R01-NS087227, R01-NS27036)
Target ALS
- License Information
-
More Information
Article History
Received: 14 October 2019
Accepted: 28 February 2020
First Online: 13 April 2020
Competing interests
: D.W.C. is a consultant for Ionis Pharmaceuticals. The other authors report no conflicts of interest.
